Actively Recruiting
Three-level Model of DBT-informed Care for Youth With and/or at Familial Risk for Bipolar Disorder (DB3)
Led by Centre for Addiction and Mental Health · Updated on 2025-11-19
60
Participants Needed
1
Research Sites
225 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study seeks to bridge the knowledge-to-action gap regarding psychosocial treatment "dosing" for youth with and/or at familial risk for bipolar disorder (BD). In psychiatry, pragmatic collaborative decisions between patient and care provider about pharmacological titrations and tapers are common. Less frequently are there considerations made regarding the pragmatic dosing of psychosocial interventions. Whereas some youth clearly require full/"high-dose" treatment, others may benefit from "lower-dose" interventions, alongside re-evaluation of dosing needs over time. Furthermore, there is a subset of youth who do not require or do not want the intensity and frequency of treatment that current interventions provide. This research presents a unique opportunity to better understand different levels of care within a subspecialized outpatient mental health clinic serving youth with and/or at familial risk for BD who vary greatly in terms of risk indicators, type and severity of symptoms, associated distress, and compounding functional impairment.
CONDITIONS
Official Title
Three-level Model of DBT-informed Care for Youth With and/or at Familial Risk for Bipolar Disorder (DB3)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- English-speaking
- Age 13 years, 0 months to 23 years, 11 months
- Meet diagnostic criteria for bipolar disorder by KSADS-PL (under 20 years) or SCID-5-RV (20 years or older) OR have a biological parent or sibling with bipolar disorder type I or II confirmed by KSADS-PL or SCID-5-RV
- If diagnosed with bipolar I disorder, taking at least one mood stabilizing medication (antimanic anticonvulsant, antipsychotic, and/or lithium)
- Followed by a psychiatrist who provides ongoing care
- Able and willing to give informed consent or assent to participate
You will not qualify if you...
- Evidence of mental retardation, moderate to severe autism spectrum disorder, or organic central nervous system disorder that would interfere with active participation in DBT
- A life-threatening medical condition requiring immediate treatment
- Current victim of sexual or physical abuse
- Current substance use disorder other than mild cannabis or alcohol use disorder
- Meets assessment criteria for Level 3 at enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre for Addiction and Mental Health
Toronto, Ontario, Canada, M6J 1H4
Actively Recruiting
Research Team
A
Amanda Moss, MSW
CONTACT
D
Danielle Curcio, MSW
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here